Skip to main content

Table 1 Summary of methods and results after adjustment for potential confounders

From: Design of cohort studies in chronic diseases using routinely collected databases when a prescription is used as surrogate outcome

Study design

Outcome

Statistical methods

Estimate of effect of statin exposure *

P

Matched cohort

Use of OS in the observation period

Conditional logistic regression

Odds ratio 1.064 (0.879,1.288)

0.523

 

Number of days on OS therapy in the observation period

Zero inflated negative binomial model

a) Odds ratio 1.025 (0.900,1.169)

0.704

   

b) Rate ratio 0.879 (0.758,1.021)

0.091

Unmatched cohort ^

Time to initiation of OS therapy

Cox model

Hazard ratio 0.956 (0.901,1.015)

0.14

 

Time to cessation of OS therapy

Cox model

Hazard ratio 0.954 (0.866,1.051)

0.34

  1. *Baseline reference: not exposed to statins
  2. ^Results presented in reference [8]